A detailed history of Cambridge Trust CO transactions in Haleon PLC stock. As of the latest transaction made, Cambridge Trust CO holds 185 shares of HLN stock, worth $1,794. This represents 0.0% of its overall portfolio holdings.

Number of Shares
185
Previous 285 35.09%
Holding current value
$1,794
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 30, 2024

SELL
$8.02 - $8.67 $802 - $867
-100 Reduced 35.09%
185 $1,000
Q4 2023

Jan 31, 2024

BUY
$7.78 - $8.62 $778 - $861
100 Added 54.05%
285 $2,000
Q2 2023

Jul 25, 2023

SELL
$8.04 - $9.0 $2,202 - $2,466
-274 Reduced 59.69%
185 $1,000
Q4 2022

Jan 09, 2023

BUY
$5.96 - $8.06 $2,735 - $3,699
459 New
459 $4,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Cambridge Trust CO Portfolio

Follow Cambridge Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Trust CO with notifications on news.